SCHEMBL17166417

SCHEMBL17166417

CCCCCCCCCCCCCCCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1(C)NN1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 9/20 0.52
▸ NPY5R Q15761 8/20 0.52
▸ NPY1R P25929 7/20 0.52
▸ NPY2R P49146 5/20 0.52
▸ IL23R Q5VWK5 2/20 0.49
▸ NPBWR1 P48145 2/20 0.47
▸ GRIA1 P42261 1/20 0.47
▸ CD40 P25942 2/20 0.46
▸ CHRND Q07001 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14479404 0.92 NPY4R (0.52) NPY4RNPY5RNPY1RNPY2RIL23R
SCHEMBL14479393 0.90 NPY4R (0.66) NPY4RNPY5RNPY1RNPY2RNPBWR1
SCHEMBL14479416 0.89 NPY4R (0.67) NPY4RNPY5RNPY1RNPY2RNPBWR1
SCHEMBL17166399 0.88 GRIA1 (0.55) GRIA1CD40CHRND
SCHEMBL14479430 0.87 NPY4R (0.50) NPY4RNPY5RNPY1RNPY2RIL23R
SCHEMBL17166418 0.84 NPY4R (0.56) NPY4RNPY5RNPY1RNPY2RNPBWR1
SCHEMBL17166409 0.84 NPY4R (0.56) NPY4RNPY5RNPY1RNPY2RNPBWR1
SCHEMBL16507934 0.84 NPY4R (0.65) NPY4RNPY5RNPY1RNPY2RGRIA1
SCHEMBL14479447 0.82 NPY4R (0.63) NPY4RNPY5RNPY1RNPY2RNPBWR1
SCHEMBL14479394 0.82 GRIA1 (0.55) NPY4RNPY5RNPY1RNPY2RGRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9155795-B2 CXCR4 receptor compounds ANCHOR THERAPEUTICS, INC. (US) 2015-10-13 — — US disclosed
Send feedback